Aurobindo Pharma's ANDA218359 for Acetaminophen and Ibuprofen Receives AP Status
Aurobindo Pharma's ANDA218359 for a combination of acetaminophen and ibuprofen has received an Abbreviated Approval (AP) status from the FDA.
Therapeutic Area
Therapeutic area intelligence for Analgesics with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.